Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

Clinical trial NCT00648999 · COMPLETED

Trial details

NCT number: NCT00648999
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Human Immunodeficiency Virus

Start date: 2003-11-01
Primary completion: 2006-12-01
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.